Published in Herz on November 01, 2008
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol (2008) 3.98
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18
Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study. Neurology (2012) 2.60
MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol (2006) 2.42
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke (2002) 2.33
Smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke. Stroke (2013) 2.11
Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro. Stroke (2005) 2.06
Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock? Stroke (2009) 1.99
Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke (2003) 1.90
Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke (2003) 1.90
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Acute stroke magnetic resonance imaging: current status and future perspective. Neuroradiology (2009) 1.59
Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke (2004) 1.58
Search for a map and threshold in perfusion MRI to accurately predict tissue fate: a protocol for assessing lesion growth in patients with persistent vessel occlusion. Cerebrovasc Dis (2011) 1.53
3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study. J Cardiovasc Electrophysiol (2012) 1.52
Fully automated postprocessing carries a risk of substantial overestimation of perfusion deficits in acute stroke magnetic resonance imaging. Cerebrovasc Dis (2011) 1.50
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc (2006) 1.45
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke (2013) 1.29
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19
Mobile computed tomography: prehospital diagnosis and treatment of stroke. Curr Opin Neurol (2015) 1.18
Prospective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset - 1000Plus study. BMC Neurol (2009) 1.08
Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset. J Cereb Blood Flow Metab (2012) 1.03
Fluid-attenuated inversion recovery images and stroke outcome after thrombolysis. Stroke (2011) 1.03
Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial. Stroke (2011) 1.03
Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials. Stroke (2012) 1.00
Hyperintense acute reperfusion marker on FLAIR is not associated with early haemorrhagic transformation in the elderly. Eur Radiol (2010) 0.99
White matter lesion severity in mild acute ischemic stroke patients and functional outcome after 1 year. Stroke (2012) 0.98
Clinical and radiological courses do not differ between fluid-attenuated inversion recovery-positive and negative patients with stroke after thrombolysis. Stroke (2010) 0.97
Complete early reversal of diffusion-weighted imaging hyperintensities after ischemic stroke is mainly limited to small embolic lesions. Stroke (2013) 0.96
Hyperintense vessels on acute stroke fluid-attenuated inversion recovery imaging: associations with clinical and other MRI findings. Stroke (2012) 0.93
PHANTOM-S: the prehospital acute neurological therapy and optimization of medical care in stroke patients - study. Int J Stroke (2012) 0.91
Optical bedside monitoring of cerebral perfusion: technological and methodological advances applied in a study on acute ischemic stroke. J Biomed Opt (2011) 0.91
Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores. J Stroke Cerebrovasc Dis (2013) 0.90
Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations. Stroke (2003) 0.89
Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke. Stroke (2013) 0.89
Dynamic hysteresis between gradient echo and spin echo attenuations in dynamic susceptibility contrast imaging. Magn Reson Med (2012) 0.87
Intracranial hemorrhage: the role of magnetic resonance imaging. Neurocrit Care (2004) 0.87
Evolution of early perihemorrhagic changes--ischemia vs. edema: an MRI study in rats. Exp Neurol (2005) 0.85
The role of imaging in acute ischemic stroke. Neurosurg Focus (2014) 0.85
Diffusion-weighted imaging in acute stroke--a tool of uncertain value? Cerebrovasc Dis (2002) 0.85
The progressive course of neurological symptoms in anterior choroidal artery infarcts. Int J Stroke (2013) 0.85
Vessel size imaging reveals pathological changes of microvessel density and size in acute ischemia. J Cereb Blood Flow Metab (2011) 0.84
Initial ischemic event: perfusion-weighted MR imaging and apparent diffusion coefficient for stroke evolution. Radiology (2005) 0.84
Modern imaging of the infarct core and the ischemic penumbra in acute stroke patients: CT versus MRI. Expert Rev Cardiovasc Ther (2009) 0.83
Visual and region of interest-based inter-rater agreement in the assessment of the diffusion-weighted imaging- fluid-attenuated inversion recovery mismatch. Stroke (2014) 0.83
Judgment of FLAIR signal change in DWI-FLAIR mismatch determination is a challenge to clinicians. J Neurol (2011) 0.83
Safety and reliability of the insertable Reveal XT recorder in patients undergoing 3 Tesla brain magnetic resonance imaging. Heart Rhythm (2010) 0.82
Automated vs manual delineations of regions of interest- a comparison in commercially available perfusion MRI software. BMC Med Imaging (2012) 0.82
Reliable perfusion maps in stroke MRI using arterial input functions derived from distal middle cerebral artery branches. Stroke (2009) 0.82
Subcellular localization of collapsin response mediator proteins to lipid rafts. Biochem Biophys Res Commun (2003) 0.82
Diagnostic transcranial ultrasound perfusion-imaging at 2.5 MHz does not affect the blood-brain barrier. Ultrasound Med Biol (2007) 0.82
A software tool for interactive exploration of intrinsic functional connectivity opens new perspectives for brain surgery. Acta Neurochir (Wien) (2011) 0.81
The potential of microvessel density in prediction of infarct growth: a two-month experimental study in vessel size imaging. Cerebrovasc Dis (2012) 0.81
Silent new DWI lesions within the first week after stroke. Cerebrovasc Dis (2012) 0.81
Early new diffusion-weighted imaging lesions appear more often in stroke patients with a multiple territory lesion pattern. Stroke (2013) 0.81
Brain imaging in acute ischemic stroke—MRI or CT? Curr Neurol Neurosci Rep (2015) 0.81
Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Stroke (2004) 0.80
Early time course of FLAIR signal intensity differs between acute ischemic stroke patients with and without hyperintense acute reperfusion marker. Cerebrovasc Dis (2014) 0.80
Neuropsychological effects of MRI-detected brain lesions after left atrial catheter ablation for atrial fibrillation: long-term results of the MACPAF study. Circ Arrhythm Electrophysiol (2013) 0.79
Elevated levels of hemoglobin A1c are associated with cerebral white matter disease in patients with stroke. Stroke (2014) 0.79
Incidence of new diffusion-weighted imaging lesions outside the area of initial hypoperfusion within 1 week after acute ischemic stroke. Stroke (2012) 0.78
ABCD(2) as a screening tool for cerebral infarction on stroke MRI? Eur Neurol (2012) 0.78
Validity of negative high-resolution diffusion-weighted imaging in transient acute cerebrovascular events. Stroke (2013) 0.78
Variable platelet response to aspirin in patients with ischemic stroke. Cerebrovasc Dis (2007) 0.78
Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial. BMC Neurol (2013) 0.78
Bilateral cerebral air embolism. J Neurol (2003) 0.77
Mesh ablator vs. cryoballoon pulmonary vein ablation of symptomatic paroxysmal atrial fibrillation: results of the MACPAF study. Europace (2012) 0.77
Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study. Cerebrovasc Dis (2013) 0.77
No microstructural white matter alterations in chronic and episodic migraineurs: a case-control diffusion tensor magnetic resonance imaging study. Headache (2015) 0.77
Statins and cerebral perfusion in patients with leukoaraiosis--a translational proof-of-principal MRI study. Int J Stroke (2012) 0.77
Biomarkers and perfusion--training-induced changes after stroke (BAPTISe): protocol of an observational study accompanying a randomized controlled trial. BMC Neurol (2013) 0.77
Stroke risk associated with balloon based catheter ablation for atrial fibrillation: Rationale and design of the MACPAF Study. BMC Neurol (2010) 0.77
Evaluation of an AIF correction algorithm for dynamic susceptibility contrast-enhanced perfusion MRI. Magn Reson Med (2008) 0.77
Aldolase C/zebrin II is released to the extracellular space after stroke and inhibits the network activity of cortical neurons. Neurochem Res (2006) 0.76
Adapting the computed tomography criteria of hemorrhagic transformation to stroke magnetic resonance imaging. Cerebrovasc Dis Extra (2013) 0.76
Glial Fibrillary Acidic Protein for Prehospital Diagnosis of Intracerebral Hemorrhage. Cerebrovasc Dis (2016) 0.75
Author Response. Neurology (2016) 0.75
Fasting versus post-challenge triglycerides and pre-existing cavitating lacunes: a berlin "cream & sugar" substudy. Front Neurol (2013) 0.75
Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke (2008) 0.75
Rate of cardiac arrhythmias and silent brain lesions in experienced marathon runners: rationale, design and baseline data of the Berlin Beat of Running study. BMC Cardiovasc Disord (2012) 0.75
Thrombolytic therapy in total mismatch with severe stroke after acute MCA-occlusion and negative DWI. Clin Neurol Neurosurg (2012) 0.75
Clinical-Radiological Parameters Improve the Prediction of the Thrombolysis Time Window by Both MRI Signal Intensities and DWI-FLAIR Mismatch. Cerebrovasc Dis (2016) 0.75
Partial rescue of the perfusion deficit area by thrombolysis. J Magn Reson Imaging (2005) 0.75
The heart and brain imaging in lone atrial fibrillation - are we surprised? Curr Pharm Des (2015) 0.75
Collapsin response mediator proteins of neonatal rat brain interact with chondroitin sulfate. J Biol Chem (2002) 0.75
Diagnostic imaging for acute ischemic stroke management. Expert Rev Med Devices (2006) 0.75
MRI follow-up after 24 h is an accurate surrogate parameter for treatment success after thrombolysis. Cerebrovasc Dis (2013) 0.75
Distal Middle Cerebral Artery Branch Recanalization Does Not Affect Final Lesion Volume in Ischemic Stroke. Cerebrovasc Dis (2017) 0.75
Ocular hyperintense acute reperfusion marker. Neurology (2012) 0.75